
Traws Pharma Investor Relations Material
Latest events

Q2 2024
Traws Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Traws Pharma Inc
Access all reports
Traws Pharma Inc. is a clinical-stage biopharmaceutical company specializing in the development of oral small molecule therapies for respiratory viral diseases and cancer. The company focuses on creating novel treatments for conditions such as influenza, COVID-19, and various cancers, utilizing advanced drug development technologies including artificial intelligence and machine learning. The company is headquartered in Newtown, Pennsylvania, and its shares are listed on NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
TRAW
Country
🇺🇸 United States